Acorah Software Products - Accounts Production 19.1.200 false true true 31 December 2024 1 January 2024 false 1 January 2025 31 December 2025 31 December 2025 13232358 Dr D Brindley Dr A Carter iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 13232358 2024-12-31 13232358 2025-12-31 13232358 2025-01-01 2025-12-31 13232358 frs-core:SharePremium 2025-12-31 13232358 frs-core:ShareCapital 2025-12-31 13232358 frs-core:RetainedEarningsAccumulatedLosses 2025-12-31 13232358 frs-bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 13232358 frs-bus:FilletedAccounts 2025-01-01 2025-12-31 13232358 frs-bus:SmallEntities 2025-01-01 2025-12-31 13232358 frs-bus:AuditExempt-NoAccountantsReport 2025-01-01 2025-12-31 13232358 frs-bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 13232358 frs-bus:Director1 2025-01-01 2025-12-31 13232358 frs-bus:Director2 2025-01-01 2025-12-31 13232358 frs-countries:EnglandWales 2025-01-01 2025-12-31 13232358 2023-12-31 13232358 2024-12-31 13232358 2024-01-01 2024-12-31 13232358 frs-core:CurrentFinancialInstruments 2024-12-31 13232358 frs-core:SharePremium 2024-12-31 13232358 frs-core:ShareCapital 2024-12-31 13232358 frs-core:RetainedEarningsAccumulatedLosses 2024-12-31
Registered number: 13232358
Biolacuna Holdco 1 Limited
Unaudited Financial Statements
For The Year Ended 31 December 2025
Biolacuna Holdco 1 Limited
Contents
Contents

| Page
--- | ---
Balance Sheet | 1—2
Notes to the Financial Statements | 3—4

Page 1
Biolacuna Holdco 1 Limited
Balance Sheet
As At 31 December 2025
Balance Sheet
Registered number: 13232358

| 2025 | 2024
--- | --- | ---
| Notes | £ | £ | £ | £
CURRENT ASSETS
Debtors | 4 | 369 |  | 195 |
Cash at bank and in hand |  | 9,260 |  | 13,099 |
|  | 9,629 |  | 13,294 |
Creditors: Amounts Falling Due Within One Year | 5 | (1,095 ) |  | (1,383 ) |
NET CURRENT ASSETS (LIABILITIES) |  |  | 8,534 |  | 11,911
TOTAL ASSETS LESS CURRENT LIABILITIES |  |  | 8,534 |  | 11,911
NET ASSETS |  |  | 8,534 |  | 11,911
CAPITAL AND RESERVES
Called up share capital | 6 |  | 35 |  | 35
Share premium account |  |  | 349,965 |  | 349,965
Profit and Loss Account |  |  | (341,466 ) |  | (338,089 )
SHAREHOLDERS' FUNDS |  |  | 8,534 |  | 11,911

Page 1
Page 2
Biolacuna Holdco 1 Limited
Balance Sheet (continued)
As At 31 December 2025
For the year ending 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board

Dr D Brindley Director | Dr A Carter Director
29 April 2026

The notes on pages 3 to 4 form part of these financial statements.
Page 2
Page 3
Biolacuna Holdco 1 Limited
Notes to the Financial Statements
For The Year Ended 31 December 2025
Notes to the Financial Statements
1. General Information
Biolacuna Holdco 1 Limited is a private company, limited by shares, incorporated in England & Wales, registered number 13232358 . The registered office is 2 The Old Estate Yard, High Street, East Hendred, Wantage, Oxfordshire, OX12 8JY.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
2.2. Going Concern Disclosure
At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.
2.3. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and assets reflect the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.
Current and deferred tax are recognised in profit or loss for the year, except when they relate to items that are recognised in other comprehensive income or directly in equity, in which case current and deferred tax are recognised in other comprehensive income or directly in equity respectively.
Page 3
Page 4
Biolacuna Holdco 1 Limited
Notes to the Financial Statements (continued)
For The Year Ended 31 December 2025
3. Average Number of Employees
Average number of employees, including directors, during the year was: 2 (2024: 2)
2 2
4. Debtors

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Due within one year
Other debtors | 369 |  | 195

5. Creditors: Amounts Falling Due Within One Year

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Trade creditors | - |  | 318
Other creditors | 1,095 |  | 1,065
| 1,095 |  | 1,383

6. Share Capital

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Allotted, Called up and fully paid | 35 |  | 35

Page 4